2026 FDA Drug Approvals
~500 rows
~120 KB CSV
Updated daily
United States
2026
Free
Download
About this dataset
Comprehensive 2026 FDA approvals dataset covering new molecular entities (NMEs), supplemental new drug applications (sNDAs), supplemental biologics license applications (sBLAs), and biosimilar approvals. Sourced from Drugs@FDA daily, cross-referenced with FDA Advisory Committee briefing documents and sponsor 8-K filings.
Schema
| Column | Description | Type |
|---|---|---|
drug_id | Drug Landscape stable identifier (URL slug) | |
brand_name | Trade name / brand name | |
generic_name | Non-proprietary (generic) name | |
company_name | Marketing applicant / sponsor | |
approval_date | FDA approval action date (ISO 8601) | |
application_number | FDA application number (NDA or BLA) | |
therapeutic_area | Primary therapeutic area | |
drug_class | Pharmacologic class | |
mechanism | Mechanism of action (one-sentence) |
Sources
Drugs@FDA, FDA Orange Book, FDA Advisory Committee briefing documents, sponsor 8-K filings.
Citation
APA
Drug Landscape. (2026). 2026 FDA Drug Approvals (Version 2026.05) [Data set]. Drug Landscape. https://druglandscape.com/datasets/fda-approvals-2026
BibTeX
@dataset{DrugLandscape2026FDAApprovals,
author = {Drug Landscape},
title = {2026 FDA Drug Approvals},
year = {2026},
version = {2026.05},
publisher = {Drug Landscape},
url = {https://druglandscape.com/datasets/fda-approvals-2026},
note = {~500 rows; source: Drugs@FDA, FDA Orange Book, FDA Advisory Committee briefing documents, sponsor 8-K filings}
}
RIS
TY - DATA T1 - 2026 FDA Drug Approvals AU - Drug Landscape PY - 2026 ET - 2026.05 PB - Drug Landscape UR - https://druglandscape.com/datasets/fda-approvals-2026 ER -
License
Free for any use including commercial, with attribution to Drug Landscape (druglandscape.com). Full terms in our editorial policy.